CRT 2025

Live Case Broadcasting from Georgia Heart Institute | Gainesville, GA

Live Case Operator(s)

• 

  Stephane Rinfret, MD, SM

  Director of Complex Coronary Interventions
  Georgia Heart Institute
  Gainesville, Georgia, United States

  Disclosure information not submitted.

Panel Moderator(s)

• 

  Lorenzo Azzalini, MD, PhD, MSc

  Interventional Cardiologist
  University of Washington
  Seattle, Washington, United States

  Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); GE Healthcare: Consulting Fees (e.g., advisory boards) (Terminated, December 11, 2024); HeartFlow: Consulting Fees (e.g., advisory boards) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Shockwave Medical, Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Kevin Croce, MD, PhD

  Director of CTO and Complex PCI Programs
  Brigham and Women's Hospital
  Harvard Medical School
  Boston, Massachusetts, United States

  Disclosure information not submitted.
• 

  Carlo Di Mario, MD

  Professor
  University of Florence
  Florence, Toscana, Italy

  Disclosure(s): BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Terminated, September 7, 2023)
• MP

  Megha Prasad, MD

  Assistant professor
  Columbia university

  Disclosure information not submitted.

Panel Discussant(s)

• 

  Emmanouil S. Brilakis, MD, PhD

  Director, Center for Advanced Coronary Interventions
  Minneapolis Heart Institute
  Minneapolis, Minnesota, United States

  Disclosure(s): Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); boston scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cleerly Health: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Elsevier Publishing: royalties (Ongoing); GE Healthcare: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Haemonetics: Consulting Fees (e.g., advisory boards) (Ongoing); Hippocrates LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); IMDS: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MHI Ventures: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Stallion Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TrueVue Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
• 

  Allison B. Hall, MD, FRCPC

  Interventional Cardiologist, Clinical Assistant Professor of Medicine
  NL Health Services/Memorial University of Newfoundland
  St. John's, Newfoundland and Labrador, Canada

  Disclosure information not submitted.
• 

  Tarek Helmy, MD, FACC, MSCAI

  Chief of Cardiology and Director of Cardiac Cath Lab
  Ochsner LSU
  Shreveport, Louisiana, United States

  Disclosure(s): medtronic.: proctor for TAVR (Ongoing)
• 

  Gautam Kumar, MD, FSCAI

  Professor
  Emory University / Atlanta VA Medical Center
  Atlanta, Georgia, United States

  Disclosure(s): Merit Medical Systems Inc: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Shigeru Saito, MD, FACC, FSCAI

  Director, Heart Center
  Shonan Kamakura General Hospital
  Kamakura, Kanagawa, Japan

  Disclosure information not submitted.
• 

  Alpesh Shah, MD

  Director of Coronary Interventions, Associate Professor
  Houston Methodist Hospital
  Houston, Texas, United States

  Disclosure information not submitted.
• 

  Gerald S. Werner, MD, PhD, FSCAI

  Director
  Klinikum Darmstadt GmbH
  Darmstadt, Hessen, Germany

  Disclosure information not submitted.
• 

  Masahisa Yamane, MD

  Senior Advisor
  Saitama Sekishinkai Hospital
  Tokyo, Tokyo, Japan

  Disclosure(s): Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing)